Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2000 Jul;59(7):497–499. doi: 10.1136/ard.59.7.497

Rheumatoid arthritis and Epstein-Barr virus: a case of living with the enemy?

W OLLIER 1
PMCID: PMC1753195  PMID: 10873955

Full Text

The Full Text of this article is available as a PDF (106.3 KB).

Figure 1  .

Figure 1  

Open in a new tab

A possible model for Epstein-Barr virus (EBV) in rheumatoid arthritis.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albani S., Carson D. A. A multistep molecular mimicry hypothesis for the pathogenesis of rheumatoid arthritis. Immunol Today. 1996 Oct;17(10):466–470. doi: 10.1016/0167-5699(96)20029-g. [DOI] [PubMed] [Google Scholar]
  2. Albani S., Keystone E. C., Nelson J. L., Ollier W. E., La Cava A., Montemayor A. C., Weber D. A., Montecucco C., Martini A., Carson D. A. Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis. Nat Med. 1995 May;1(5):448–452. doi: 10.1038/nm0595-448. [DOI] [PubMed] [Google Scholar]
  3. Bonneville M., Scotet E., Peyrat M. A., Saulquin X., Houssaint E. Epstein-Barr virus and rheumatoid arthritis. Rev Rhum Engl Ed. 1998 Jun;65(6):365–368. [PubMed] [Google Scholar]
  4. Cook A. D., Davies J. M., Myers M. A., Mackay I. R., Rowley M. J. Mimotopes identified by phage display for the monoclonal antibody CII-C1 to type II collagen. J Autoimmun. 1998 Jun;11(3):205–211. doi: 10.1006/jaut.1998.0200. [DOI] [PubMed] [Google Scholar]
  5. Devergne O., Hummel M., Koeppen H., Le Beau M. M., Nathanson E. C., Kieff E., Birkenbach M. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J Virol. 1996 Feb;70(2):1143–1153. doi: 10.1128/jvi.70.2.1143-1153.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Di Girolamo N., Tedla N., Lloyd A., Wakefield D. Expression of matrix metalloproteinases by human plasma cells and B lymphocytes. Eur J Immunol. 1998 Jun;28(6):1773–1784. doi: 10.1002/(SICI)1521-4141(199806)28:06<1773::AID-IMMU1773>3.0.CO;2-B. [DOI] [PubMed] [Google Scholar]
  7. Di Girolamo N., Visvanathan K., Lloyd A., Wakefield D. Expression of TNF-alpha by human plasma cells in chronic inflammation. J Leukoc Biol. 1997 Jun;61(6):667–678. doi: 10.1002/jlb.61.6.667. [DOI] [PubMed] [Google Scholar]
  8. Dolcetti R., Zancai P., Cariati R., Boiocchi M. In vitro effects of retinoids on the proliferation and differentiation features of Epstein-Barr virus-immortalized B lymphocytes. Leuk Lymphoma. 1998 Apr;29(3-4):269–281. doi: 10.3109/10428199809068564. [DOI] [PubMed] [Google Scholar]
  9. Edinger J. W., Bonneville M., Scotet E., Houssaint E., Schumacher H. R., Posnett D. N. EBV gene expression not altered in rheumatoid synovia despite the presence of EBV antigen-specific T cell clones. J Immunol. 1999 Mar 15;162(6):3694–3701. [PubMed] [Google Scholar]
  10. Fawcett M. C., Walker D. J., Griffiths I. D. Demonstration of impaired T cell regulation of Epstein-Barr virus stimulated B lymphocytes in rheumatoid arthritis with HLA identical, disease discordant sibling pairs. Ann Rheum Dis. 1988 May;47(5):372–376. doi: 10.1136/ard.47.5.372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fox R. I., Luppi M., Pisa P., Kang H. I. Potential role of Epstein-Barr virus in Sjögren's syndrome and rheumatoid arthritis. J Rheumatol Suppl. 1992 Jan;32:18–24. [PubMed] [Google Scholar]
  12. Fox R. I., Pearson G., Vaughan J. H. Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjogren's syndrome. J Immunol. 1986 Nov 15;137(10):3162–3168. [PubMed] [Google Scholar]
  13. Gregersen P. K., Silver J., Winchester R. J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987 Nov;30(11):1205–1213. doi: 10.1002/art.1780301102. [DOI] [PubMed] [Google Scholar]
  14. Haier J., Nasralla M., Franco A. R., Nicolson G. L. Detection of mycoplasmal infections in blood of patients with rheumatoid arthritis. Rheumatology (Oxford) 1999 Jun;38(6):504–509. doi: 10.1093/rheumatology/38.6.504. [DOI] [PubMed] [Google Scholar]
  15. Koide J., Takada K., Sugiura M., Sekine H., Ito T., Saito K., Mori S., Takeuchi T., Uchida S., Abe T. Spontaneous establishment of an Epstein-Barr virus-infected fibroblast line from the synovial tissue of a rheumatoid arthritis patient. J Virol. 1997 Mar;71(3):2478–2481. doi: 10.1128/jvi.71.3.2478-2481.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. La Cava A., Nelson J. L., Ollier W. E., MacGregor A., Keystone E. C., Thorne J. C., Scavulli J. F., Berry C. C., Carson D. A., Albani S. Genetic bias in immune responses to a cassette shared by different microorganisms in patients with rheumatoid arthritis. J Clin Invest. 1997 Aug 1;100(3):658–663. doi: 10.1172/JCI119577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lechman E. R., Jaffurs D., Ghivizzani S. C., Gambotto A., Kovesdi I., Mi Z., Evans C. H., Robbins P. D. Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees. J Immunol. 1999 Aug 15;163(4):2202–2208. [PubMed] [Google Scholar]
  18. Miyazawa K., Mori A., Yamamoto K., Okudaira H. Transcriptional roles of CCAAT/enhancer binding protein-beta, nuclear factor-kappaB, and C-promoter binding factor 1 in interleukin (IL)-1beta-induced IL-6 synthesis by human rheumatoid fibroblast-like synoviocytes. J Biol Chem. 1998 Mar 27;273(13):7620–7627. doi: 10.1074/jbc.273.13.7620. [DOI] [PubMed] [Google Scholar]
  19. Mousavi-Jazi M., Boström L., Lövmark C., Linde A., Brytting M., Sundqvist V. A. Infrequent detection of cytomegalovirus and Epstein-Barr virus DNA in synovial membrane of patients with rheumatoid arthritis. J Rheumatol. 1998 Apr;25(4):623–628. [PubMed] [Google Scholar]
  20. Newkirk M. M., Duffy K. N., Paleckova A., Ivaskova E., Galianova A., Seeman J., Vojtechovsky K., Dostal C. Herpes viruses in multicase families with rheumatoid arthritis. J Rheumatol. 1995 Nov;22(11):2055–2061. [PubMed] [Google Scholar]
  21. Ollier W. E., MacGregor A. Genetic epidemiology of rheumatoid disease. Br Med Bull. 1995 Apr;51(2):267–285. doi: 10.1093/oxfordjournals.bmb.a072960. [DOI] [PubMed] [Google Scholar]
  22. Ollier W., Worthington J. Small fish in a big pond. Br J Rheumatol. 1997 Sep;36(9):931–932. doi: 10.1093/rheumatology/36.9.931. [DOI] [PubMed] [Google Scholar]
  23. Roudier J., Petersen J., Rhodes G. H., Luka J., Carson D. A. Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5104–5108. doi: 10.1073/pnas.86.13.5104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Roudier J., Rhodes G., Petersen J., Vaughan J. H., Carson D. A. The Epstein-Barr virus glycoprotein gp110, a molecular link between HLA DR4, HLA DR1, and rheumatoid arthritis. Scand J Immunol. 1988 Apr;27(4):367–371. doi: 10.1111/j.1365-3083.1988.tb02359.x. [DOI] [PubMed] [Google Scholar]
  25. Saal J. G., Krimmel M., Steidle M., Gerneth F., Wagner S., Fritz P., Koch S., Zacher J., Sell S., Einsele H. Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope. Arthritis Rheum. 1999 Jul;42(7):1485–1496. doi: 10.1002/1529-0131(199907)42:7<1485::AID-ANR24>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
  26. Saal J. G., Steidle M., Einsele H., Müller C. A., Fritz P., Zacher J. Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis. Rheumatol Int. 1992;12(4):147–151. doi: 10.1007/BF00274934. [DOI] [PubMed] [Google Scholar]
  27. Sibilia J., Lioté F., Mariette X. Lymphoproliferative disorders in rheumatoid arthritis patients on low-dose methotrexate. Rev Rhum Engl Ed. 1998 Apr;65(4):267–273. [PubMed] [Google Scholar]
  28. Silins S. L., Cross S. M., Krauer K. G., Moss D. J., Schmidt C. W., Misko I. S. A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infection. J Clin Invest. 1998 Oct 15;102(8):1551–1558. doi: 10.1172/JCI4225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Takei M., Mitamura K., Fujiwara S., Horie T., Ryu J., Osaka S., Yoshino S., Sawada S. Detection of Epstein-Barr virus-encoded small RNA 1 and latent membrane protein 1 in synovial lining cells from rheumatoid arthritis patients. Int Immunol. 1997 May;9(5):739–743. doi: 10.1093/intimm/9.5.739. [DOI] [PubMed] [Google Scholar]
  30. Toussirot E., Auger I., Roudier C., Luka J., Wendling D., Tiberghien P., Roudier J. HLA-DR polymorphism influences T-cell precursor frequencies to Epstein-Barr virus (EBV) gp110: implications for the association of HLA-DR antigens with rheumatoid arthritis. Tissue Antigens. 1999 Aug;54(2):146–152. doi: 10.1034/j.1399-0039.1999.540205.x. [DOI] [PubMed] [Google Scholar]
  31. Wall E. M., Cao J. X., Upton C. Subversion of cytokine networks by viruses. Int Rev Immunol. 1998;17(1-4):121–155. doi: 10.3109/08830189809084490. [DOI] [PubMed] [Google Scholar]
  32. Zancai P., Cariati R., Rizzo S., Boiocchi M., Dolcetti R. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event. Oncogene. 1998 Oct 8;17(14):1827–1836. doi: 10.1038/sj.onc.1202089. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES